Fate Therapeutics, Inc.
FATENASDAQHealthcare● Active
$1.91
$-0.07(-3.54%)
Market Cap$222627690
P/E Ratio—
52W High$2.88
52W Low$0.91
Fate Therapeutics, Inc.（FATE）· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · FATE · 截至 2026-06-09
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $6.65M | $13.63M | $63.53M | $96.30M | $55.85M |
| Cost of Revenue | $12.90M | $0.00M | $157.19M | $13.76M | $5.85M |
| Gross Profit | ($6.25M) | $13.63M | ($93.65M) | $82.54M | $50.00M |
| Gross Margin %(computed) | -94.12% | 100.00% | -147.41% | 85.71% | 89.52% |
| Operating Expenses | |||||
| R&D Expenses | $107.83M | $135.00M | $172.60M | $320.45M | $215.52M |
| G&A Expenses | $46.52M | $74.17M | $81.45M | $84.23M | $57.32M |
| Total Operating Expenses | $141.45M | $223.91M | $96.86M | $390.93M | $266.99M |
| Operating Income | ($147.70M) | ($210.28M) | ($190.51M) | ($308.39M) | ($216.99M) |
| Operating Margin %(computed) | — | — | -299.86% | -320.23% | -388.56% |
| Interest Income | $11.05M | $17.29M | $17.19M | $5.84M | $1.31M |
| Interest Expense | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Income Before Tax | ($136.31M) | ($186.26M) | ($160.93M) | ($281.72M) | ($212.15M) |
| Income Tax Expense | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Net Income | ($136.31M) | ($186.26M) | ($160.93M) | ($281.72M) | ($212.15M) |
| Net Margin %(computed) | — | — | -253.30% | -292.55% | -379.89% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-1.15 | $-1.64 | $-1.64 | $-2.91 | $-2.24 |
| Wtd Avg Shares | 118.79M | 113.69M | 98.41M | 96.83M | 94.75M |
| EBITDA | ($127.02M) | ($176.58M) | ($172.23M) | ($294.63M) | ($211.14M) |
| EBITDA Margin %(computed) | — | — | -271.09% | -305.95% | -378.08% |
数据来源：Financial Modeling Prep · 最后更新：2026-06-09 · USD · M
深入了解Fate Therapeutics, Inc.
关于Fate Therapeutics, Inc.（FATE）损益表
Fate Therapeutics, Inc.（FATE）损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年，FATE实现营收$0.01B，毛利润($0.01B)（毛利率-94.12%），净利润($0.14B)（净利率-2051.08%）。
常见问题
FATE · 4 问Fate Therapeutics, Inc.（FATE）2025财年营收为$0.01B，同比down51.2%。
FATE revenueFATE salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09